通过在美学和治疗之间协调玻尿素毒素治疗来缓解免疫性
Stephen M Gollomp1, Saami Khalifian1,2, Samantha Gokhale3
1Lankenau Medical Center, Wynnewood, Pennsylvania.
概括
较高的美学性肉毒毒素 (BoNT) 剂量可能会降低有效性和耐药性,特别是在结合美学和治疗用途时. 医生必须通过开放的沟通和仔细的治疗计划来管理这些风险.
科学领域:
- 神经学 神经学
- 皮肤病学 皮肤病学
- 化品科学 化品科学
背景情况:
- 审美性肉毒毒素 (BoNT) 的使用已经扩大到传统的低剂量之外.
- 患者可能会接受以前为治疗用途保留的剂量.
- 结合的美学和治疗性BoNT治疗增加了风险.
研究的目的:
- 为了突出与较高的BoNT剂量相关的免疫性风险.
- 为了解决重叠治疗的患者中抗药性增加的风险.
- 为了比较BoNT剂量用于美学和治疗指示.
主要方法:
- 对当前实践的文献综述.
- 对BoNT剂量的并排比较.
- 审美与治疗指示的分析.
主要成果:
- 审美BoNT剂量可以达到或超过治疗剂量.
- 组合治疗或大面积治疗可以增加总剂量.
- 增加免疫原反应和耐药性的可能性.
结论:
- 医生必须实施风险管理策略.
- 与患者的公开对话对于治疗规划至关重要.
- 为了最大限度地提高治疗效果和寿命,需要谨慎的剂量管理.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
661
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
661
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Skeletal Muscle Relaxants: Therapeutic Uses
477
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
477
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
401
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
401
Prevention of Further Absorption of Poison
801
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
801
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
639
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
639


